Model Number MV-WB070421 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Intracranial Hemorrhage (1891)
|
Event Date 11/30/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
A search for non-conformances associated with the reported part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.The device was implanted in the patient and thus could not be returned to the manufacturer for evaluation.Fluoroscopic media was not provided.The event could not be confirmed.The instructions for use (ifu) identifies hemorrhage as a potential complication associated with use of the device.
|
|
Event Description
|
It was reported that on (b)(6) 2021, a web device was implanted in an unruptured cerebral aneurysm of the left mca.On the same day, subarachnoid hemorrhage was noted on the same side as the aneurysm.No additional treatment was performed.The patient's condition improved on (b)(6) 2021 and the patient was discharged from the hospital on (b)(6) 2021.Dapt (aspirin and clopidogrel) was started on (b)(6) 2021 after that, clopidogrel was discontinued on (b)(6) 2021, and aspirin was discontinued on (b)(6) 2021.The root cause of the sah is unknown but it was stated that a causal relationship to the device and procedure cannot be ruled out.
|
|
Manufacturer Narrative
|
A search for non-conformances associated with the reported part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.The device was implanted in the patient and thus could not be returned to the manufacturer for evaluation.Fluoroscopic media was not provided.The event could not be confirmed.The instructions for use (ifu) identifies hemorrhage as a potential complication associated with use of the device.
|
|
Event Description
|
It was reported that on (b)(6) 2021, a web device was implanted in an unruptured cerebral aneurysm of the left mca.On the same day, subarachnoid hemorrhage was noted on the same side as the aneurysm.No additional treatment was performed.The patient's condition improved on (b)(6) 2021 and the patient was discharged from the hospital on (b)(6) 2021.Dapt (aspirin and clopidogrel) was started on (b)(6) 2021 after that, clopidogrel was discontinued on (b)(6) 2021, and aspirin was discontinued on (b)(6) 2021.The root cause of the sah is unknown but it was stated that a causal relationship to the device and procedure cannot be ruled out.
|
|
Manufacturer Narrative
|
New information received via email stated that the sah occured on the same side as the web implantation site.The physician assumed the the sah was caused by the artery stretching while the microcatheter or dac was being advanced to the periphery.No imaging was available.
|
|
Search Alerts/Recalls
|